A Pan-Cancer Analysis of the Prognostic Value and Expression of Adenylate Cyclase 7 (ADCY7) in Human Tumors

References

• Hanoune J, Defer N. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol. 2001;41:145–174. doi:10.1146/annurev.pharmtox.41.1.145
   PubMed Web of Science ®Google Scholar
• Baron L, Gombault A, Fanny M, et al. The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine. Cell Death Dis. 2015;6:e1629–e.
   PubMed Web of Science ®Google Scholar
• Ludwig M-G, Seuwen K. Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms. J Receptors Signal Transd. 2002;22:79–110. doi:10.1081/RRS-120014589
   PubMed Web of Science ®Google Scholar
• Li C, Xie J, Lu Z, et al. ADCY7 supports development of acute myeloid leukemia. Biochem Biophys Res Commun. 2015;465:47–52.
   PubMed Web of Science ®Google Scholar
• Price T, Brust TF. Adenylyl cyclase 7 and neuropsychiatric disorders: a new target for depression? Pharmacol Res. 2019;143:106–112.
   PubMed Web of Science ®Google Scholar
• Jiang LI, Sternweis PC, Wang JE. Zymosan activates protein kinase A via adenylyl cyclase VII to modulate innate immune responses during inflammation. Mol Immunol. 2013;54:14–22. doi:10.1016/j.molimm.2012.10.027
   PubMed Web of Science ®Google Scholar
• Masugi Y, Tanese K, Emoto K, et al. Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma. Pathol Int. 2015;65:627–634. doi:10.1111/pin.12351
   PubMed Web of Science ®Google Scholar
• Chen SL, Hu F, Wang DW, et al. Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia. Aging. 2020;12:11864–11877. doi:10.18632/aging.103357
   PubMedGoogle Scholar
• Sethna F, Feng W, Ding Q, et al. Enhanced expression of ADCY1 underlies aberrant neuronal signalling and behaviour in a syndromic autism model. Nat Commun. 2017;8:14359. doi:10.1038/ncomms14359
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Consortium G. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318–1330.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–404. doi:10.1158/2159-8290.CD-12-0095
   PubMed Web of Science ®Google Scholar
• Csiszar A, Balasubramanian P, Tarantini S, et al. Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research. Geroscience. 2019;41:209–227. doi:10.1007/s11357-019-00064-4
   PubMed Web of Science ®Google Scholar
• Kim S, Wyckoff J, Morris AT, et al. DNA methylation associated with healthy aging of elderly twins. Geroscience. 2018;40:469–484. doi:10.1007/s11357-018-0040-0
   PubMed Web of Science ®Google Scholar
• Masser DR, Hadad N, Porter H, et al. Analysis of DNA modifications in aging research. Geroscience. 2018;40:11–29. doi:10.1007/s11357-018-0005-3
   PubMed Web of Science ®Google Scholar
• Tiffen J, Gallagher SJ, Filipp F, et al. EZH2 cooperates with DNA methylation to downregulate key tumor suppressors and IFN gene signatures in melanoma. J Invest Dermatol. 2020;140(12):2442–2454.e5. doi:10.1016/j.jid.2020.02.042
   PubMed Web of Science ®Google Scholar
• Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357:409–413. doi:10.1126/science.aan6733
   PubMed Web of Science ®Google Scholar
• Asaoka Y, Ijichi H, Koike K. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;373:1979.
   PubMed Web of Science ®Google Scholar
• Hause RJ, Pritchard CC, Shendure J, et al. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016;22:1342–1350. doi:10.1038/nm.4191
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77:e108–e10. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607–d13. doi:10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Liu S, Xie X, Lei H, et al. Identification of key circRNAs/lncRNAs/miRNAs/mRNAs and pathways in preeclampsia using bioinformatics analysis. Med Sci Monit. 2019;25:1679–1693. doi:10.12659/MSM.912801
   PubMed Web of Science ®Google Scholar
• Kammer GM. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today. 1988;9:222–229. doi:10.1016/0167-5699(88)91220-0
   PubMedGoogle Scholar
• Castro A, Jerez MJ, Gil C, et al. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors. Med Res Rev. 2005;25:229–244. doi:10.1002/med.20020
   PubMed Web of Science ®Google Scholar
• Patel TB, Du Z, Pierre S, et al. Molecular biological approaches to unravel adenylyl cyclase signaling and function. Gene. 2001;269:13–25. doi:10.1016/S0378-1119(01)00448-6
   PubMed Web of Science ®Google Scholar
• Baron L, Gombault A, Fanny M, et al. The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine. Cell Death Dis. 2015;6:e1629.
   PubMed Web of Science ®Google Scholar
• Murray F, Insel PA. Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma. Expert Opin Ther Targets. 2013;17:937–949. doi:10.1517/14728222.2013.798304
   PubMed Web of Science ®Google Scholar
• Li C, Xie J, Lu Z, et al. ADCY7 supports development of acute myeloid leukemia. Biochem Biophys Res Commun. 2015;465:47–52. doi:10.1016/j.bbrc.2015.07.123
   PubMed Web of Science ®Google Scholar
• Lancet T. Moving toward precision medicine. Lancet. 2011;378:1678. doi:10.1016/S0140-6736(11)61725-X
   Web of Science ®Google Scholar
• Cao Z, Zhang S. An integrative and comparative study of pan-cancer transcriptomes reveals distinct cancer common and specific signatures. Sci Rep. 2016;6:33398. doi:10.1038/srep33398
   PubMed Web of Science ®Google Scholar
• Armaghany T, Wilson JD, Chu Q, et al. Genetic alterations in colorectal cancer. Gastrointest Cancer Res. 2012;5:19–27.
   PubMedGoogle Scholar
• Baretti M, Le DT. DNA mismatch repair in cancer. Pharmacol Ther. 2018;189:45–62. doi:10.1016/j.pharmthera.2018.04.004
   PubMed Web of Science ®Google Scholar
• Li K, Luo H, Huang L, et al. Microsatellite instability: a review of what the oncologist should know. Cancer Cell Int. 2020;20:16. doi:10.1186/s12935-019-1091-8
   PubMed Web of Science ®Google Scholar
• Herbst RS, Baas P, Perez-Gracia JL, et al. Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial. Ann Oncol. 2019;30:281–289. doi:10.1093/annonc/mdy545
   PubMed Web of Science ®Google Scholar
• Wu HX, Wang ZX, Zhao Q, et al. Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers. Ann Transl Med. 2019;7:640. doi:10.21037/atm.2019.10.116
   PubMed Web of Science ®Google Scholar
• Havel JJ, Chowell D, Chan TA. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer. 2019;19:133–150.
   PubMed Web of Science ®Google Scholar
• Chalmers ZR, Connelly CF, Fabrizio D, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9:34. doi:10.1186/s13073-017-0424-2
   PubMed Web of Science ®Google Scholar
• Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501:346–354. doi:10.1038/nature12626
   PubMed Web of Science ®Google Scholar
• Woo JR, Liss MA, Muldong MT, et al. Tumor infiltrating B-cells are increased in prostate cancer tissue. J Transl Med. 2014;12:30. doi:10.1186/1479-5876-12-30
   PubMed Web of Science ®Google Scholar
• Ju Q, Li XM, Zhang H, et al. BRCA1-associated protein is a potential prognostic biomarker and is correlated with immune infiltration in liver hepatocellular carcinoma: a pan-cancer analysis. Front Mol Biosci. 2020;7:573619. doi:10.3389/fmolb.2020.573619
   PubMed Web of Science ®Google Scholar
• Shan X, Zhang C, Wang Z, et al. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling. Clin Immunol. 2020;216:108430. doi:10.1016/j.clim.2020.108430
   PubMed Web of Science ®Google Scholar